Patents by Inventor Eliahu Zlotkin

Eliahu Zlotkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9737571
    Abstract: A composition comprising an extract from an aquatic organism is disclosed. The composition is capable of preventing adhesion of a cell to a surface and is devoid of cytotoxic or cytostatic activity. Medical devices comprising same and methods for preventing or treating a pathological infection using same are also disclosed.
    Type: Grant
    Filed: September 21, 2008
    Date of Patent: August 22, 2017
    Assignee: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
    Inventors: Amir Zlotkin, Eliahu Zlotkin, Amir Zlotkin
  • Publication number: 20110119774
    Abstract: A composition comprising an extract from an aquatic organism is disclosed. The composition is capable of preventing adhesion of a cell to a surface and is devoid of cytotoxic or cytostatic activity. Medical devices comprising same and methods for preventing or treating a pathological infection using same are also disclosed.
    Type: Application
    Filed: September 21, 2008
    Publication date: May 19, 2011
    Applicant: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S
    Inventors: Amir Zlotkin, Eliahu Zlotkin, Amir Zlotkin
  • Publication number: 20060178293
    Abstract: A polypeptide which has a positive inotropic effect on cultured cardiomyocytes and is non-toxic to mammals. The polypeptide may be isolated from Buthinae scorpion venom. Also disclosed is a pharmaceutical composition comprising the polypeptide and a DNA molecule encoding the polypeptide.
    Type: Application
    Filed: May 19, 2004
    Publication date: August 10, 2006
    Inventors: Eliahu Zlotkin, Morris Mosseri
  • Patent number: 6689356
    Abstract: A recombinant baculovirus is provided with a genetic coding sequence for the production of a foreign protein that is toxic to insects. Preferred are nuclear polyhedrosis viruses, with preferred embodiments having been constructed and expressed in insect cells: BmNPV.AaIT and AcNPV.AaIT. Both embodiments function in insect cells infected therewith so as to have the toxin AaIT (originating from the venom of the scorpion A. australis) secreted. A clone designated (pCIB4223), which contains the Bombyx mori signal sequence fused to the AaIT sequence, has been deposited with the American type culture collection and designated “ATCC 40906.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 10, 2004
    Assignees: The Regents of the Unviersity of California, BASF Aktiengesellschaft
    Inventors: Eliahu Zlotkin, Susumu Maeda, Billy Fred McCutchen, Bruce D. Hammock, Elizabeth Fowler, Rama M. Belagaje